These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27601557)

  • 21. Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia.
    Kusters DM; Avis HJ; de Groot E; Wijburg FA; Kastelein JJ; Wiegman A; Hutten BA
    JAMA; 2014 Sep; 312(10):1055-7. PubMed ID: 25203086
    [No Abstract]   [Full Text] [Related]  

  • 22. Cholesterol and family history: when genetics matters.
    Vengoechea J; McKelvey KD
    J Ark Med Soc; 2015 Feb; 111(9):184-6. PubMed ID: 25993767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of children with heterozygous familial hypercholesterolemia.
    Reiner Ž; Sahebkar A
    Int J Cardiol; 2020 Apr; 304():177-178. PubMed ID: 31735366
    [No Abstract]   [Full Text] [Related]  

  • 24. Additive effects of another kind of HMG-CoA reductase inhibitor with different pharmacokinetics in the treatment of heterozygous familial hypercholesterolemia.
    Nozue T; Nohara A; Higashikata T; Inazu A; Mabuchi H; Kajinami K; Koizumi J
    Atherosclerosis; 2000 Dec; 153(2):525-6. PubMed ID: 11187857
    [No Abstract]   [Full Text] [Related]  

  • 25. Familial hypercholesterolaemia.
    Gill PJ; Harnden A; Karpe F
    BMJ; 2012 May; 344():e3228. PubMed ID: 22581572
    [No Abstract]   [Full Text] [Related]  

  • 26. LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.
    Vongpromek R; Bujo H; Hoekstra M; Schneider WJ; van der Zee L; Schinkel AF; Korporaal SJ; Dik WA; Ebinuma H; Jiang M; Verhoeven AJ; Sijbrands EJ; Mulder MT
    Atherosclerosis; 2015 Dec; 243(2):429-37. PubMed ID: 26520897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
    Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA
    Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. 1981.
    Mabuchi H; Haba T; Tatami R; Miyamoto S; Sakai Y; Wakasugi T; Watanabe A; Koizumi J; Takeda R
    Atheroscler Suppl; 2004 Oct; 5(3):51-5. PubMed ID: 15531275
    [No Abstract]   [Full Text] [Related]  

  • 29. Atherosclerosis progression in patients with autosomal dominant hypercholesterolemia in clinical practice.
    Jarauta E; Mateo-Gallego R; Bea AM; Crespo M; Ballester A; Rubio MV; Baila-Rueda L; Calmarza P; Cenarro A; de Groot E; Civeira F
    J Clin Lipidol; 2014; 8(4):373-80. PubMed ID: 25110218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homozygous familial hypercholesterolemia.
    Choh SA; Choh NA; Rasool A; Yousuf R; Qureshi U
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):573-5. PubMed ID: 19694206
    [No Abstract]   [Full Text] [Related]  

  • 31. Updates on the Use of Subclinical Atherosclerosis to Predict Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia.
    Gallo A; Mszar R; Miname MH
    Curr Atheroscler Rep; 2022 Jun; 24(6):407-418. PubMed ID: 35386094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins in homozygous familial hypercholesterolemia.
    Marais AD; Blom DJ; Firth JC
    Curr Atheroscler Rep; 2002 Jan; 4(1):19-25. PubMed ID: 11772418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood.
    Braamskamp MJ; Kusters DM; Wiegman A; Avis HJ; Wijburg FA; Kastelein JJ; van Trotsenburg AS; Hutten BA
    Atherosclerosis; 2015 Aug; 241(2):427-32. PubMed ID: 26079405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypolipidemic treatment of heterozygous familial hypercholesterolemia: a lifelong challenge.
    Vuorio AF; Kovanen PT; Gylling H
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):405-15. PubMed ID: 15151486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterozygous familial hypercholesterolemia: a new point-mutation (1372del2) in the LDL-receptor gene which causes severe hypercholesterolemia.
    Widhalm K; Iro C; Lindemayr A; Schmidt H; Kostner G
    Hum Mutat; 1999 Oct; 14(4):357. PubMed ID: 10502834
    [No Abstract]   [Full Text] [Related]  

  • 36. Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010.
    Mundal L; Sarancic M; Ose L; Iversen PO; Borgan JK; Veierød MB; Leren TP; Retterstøl K
    J Am Heart Assoc; 2014 Dec; 3(6):e001236. PubMed ID: 25468658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of patients with homozygous familial hypercholesterolemia.
    Ziajka PE
    Am J Manag Care; 2013 Nov; 19(13 Suppl):s. PubMed ID: 24494590
    [No Abstract]   [Full Text] [Related]  

  • 38. Heterozygous familial hypercholesterolemia case study.
    Friedrich DA
    J Am Acad Nurse Pract; 2010 Oct; 22(10):523-6. PubMed ID: 21040085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol.
    Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Ito MK; McGowan MP; Moriarty PM;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S38-45. PubMed ID: 21600528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.